RT @Vaccinologist: #COVID19 patients who had received the #flushot 6 months to 2 weeks prior to diagnosis were less likely to have sepsis,…
RT @Vaccinologist: #COVID19 patients who had received the #flushot 6 months to 2 weeks prior to diagnosis were less likely to have sepsis,…
#COVID19 patients who had received the #flushot 6 months to 2 weeks prior to diagnosis were less likely to have sepsis, stroke, deep vein thrombosis (DVTs), admission to the intensive care unit (ICU), emergency department (ED) https://t.co/dW6ZxrpNRj https
RT @RocksPowers: Examining the potential benefits of the influenza vaccine against SARS-CoV-2: A retrospective cohort analysis of 74,754 pa…
RT @sandralopezleon: 🦠 Este estudió sugiere que la vacuna d la #influenza puede evitar complicaciones de #COVID. Los no vacunados tuviero…
Protección brindada por influenza estaciones en sujetos que han con COVID-19 Interesantes datos https://t.co/b1CmoCqzVl https://t.co/UWk3PXofJe
RT @ricaordor: @VicM_RodriguezM Potential protective effect of influenza vaccination in SARS-CoV-2-positive patients against adverse outcom…
RT @sandralopezleon: 🦠 Este estudió sugiere que la vacuna d la #influenza puede evitar complicaciones de #COVID. Los no vacunados tuviero…
RT @sandralopezleon: 🦠 Este estudió sugiere que la vacuna d la #influenza puede evitar complicaciones de #COVID. Los no vacunados tuviero…
@PepePediatre Potential protective effect of influenza vaccination in SARS-CoV-2-positive patients against adverse outcomes within 30, 60, 90, and 120 days of a positive diagnosis. https://t.co/qlxilx1SqA
@saludpublicaac Potential protective effect of influenza vaccination in SARS-CoV-2-positive patients against adverse outcomes within 30, 60, 90, and 120 days of a positive diagnosis. https://t.co/qlxilx1SqA
@VicM_RodriguezM Potential protective effect of influenza vaccination in SARS-CoV-2-positive patients against adverse outcomes within 30, 60, 90, and 120 days of a positive diagnosis. https://t.co/qlxilx1SqA
Examining the potential benefits of the #influenzavaccine against #SARSCoV2: A retrospective cohort analysis of 74,754 patients » https://t.co/SCy1tBtL4B Physician-scientists @umiamimedicine have shown in a study that the #fluvaccine may provide vital prot
Examining the potential benefits of the influenza vaccine against SARS-CoV-2: A retrospective cohort analysis of 74,754 patients https://t.co/riuYPgEEsk
New NNT→Examining the potential benefits of the influenza vaccine against SARS-CoV-2: A retrospective cohort analysis of 74,754 patients https://t.co/39LpnBLrbY
New article: Examining the potential benefits of the influenza vaccine against SARS-CoV-2: A retrospective cohort analysis of 74,754 patients https://t.co/U0bTAh1wcj #coronavirus #COVID19 #2019ncov https://t.co/dq9ANyCQ17
@dannyviLe Ay, no me hagas leer artículos largos a esta hora de la noche: https://t.co/ESnMgPS8Rg
Examining the potential benefits of the influenza vaccine against SARS-CoV-2: A retrospective cohort analysis of 74,754 patients https://t.co/UzLaX4izRx #covid19
Examining the potential benefits of the influenza vaccine against SARS-CoV-2: A retrospective cohort analysis of 74,754 patients https://t.co/L8ZSu2tzcF
RT @carbauche: El estudio original https://t.co/jyraIPRQif
El estudio original https://t.co/jyraIPRQif